Bullous Pemphigoid Associated With Linagliptin Treatment
Drug-induced bullous pemphigoid (BP) has been recently reported in association with sitagliptin and vildagliptin, 2 dipeptidyl peptidase-4 (DPP-4) inhibitors used in the treatment of type 2 diabetes mellitus (T2DM). Herein, we report the development of BP in 2 patients with T2DM treated with linagliptin, another DPP-4 inhibitor.
Report of Cases | Case 1. A man in his 60s with psoriasis and T2DM presented with pruritus and erythematous tense bullae on the limbs (Figure 1) . The clinical diagnosis of BP was confirmed by histologic findings showing a subepidermal blister containing eosinophils ( Figure 2 ) and direct immunofluorescence analysis showing a linear deposit of IgG and C3 at the basement membrane zone. Enzyme-linked immunosorbent assay was performed and demonstrated reactivity with the recombinant proteins of NC16a and C-terminal domains of BP180. Treatment with topical clobetasol propionate, 0.05% (50 g/d), improved the lesions, but the patient presented with another flare of BP 2 weeks later. Linagliptin treatment, which had begun 4 months previously, was stopped. One week later, under treatment with the same topical corticosteroid applications, the lesions healed completely; there was no clinical recurrence of BP during 3 months of follow-up.
Case 2. A woman in her 70s with T2DM presented with a 2-month history of pruritus and tense bullae on the trunk. The diagnosis The mechanism by which drugs can provoke PB is unclear. The DPP-4 inhibitors may induce anti-basement membrane zone antibodies or other structurally close antibodies, leading to subepidermal bullae and BP. Inhibition of DPP-4 has been shown to enhance the recruitment of eosinophils into the dermis, 4 which may contribute to the blister formation and tissue damage observed in BP. The direct effect of gliptins on the BP180 antigen, the core target antigen in BP, has not been elucidated to date. However, in the skin, many cell types including keratinocytes constitutionally express DPP-4; the inhibition of DPP-4 might affect the epidermal basement membrane zone.
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In contrast to previously reported cases, neither of the present patients was undergoing metformin treatment, which makes this drug unlikely to be involved in the genesis of BP. In fact, metformin monotherapy has not been associated with BP. [1] [2] [3] In addition, DPP-4 is known to be upregulated in keratinocytes in psoriatic lesions. 6 The presence of psoriasis in our first case might have led to upregulation of DPP-4 in keratinocytes, thus potentiating the activity of gliptins on keratinocytes and modifying the immune response and/or altering the antigenic properties of the basement membrane and increasing the risk BP induced by DPP-4 inhibitors.
Our cases and the findings from the literature review demonstrate that BP is an adverse effect most probably shared by all types of gliptins. In view of their wide use in the treatment of T2DM, further studies are needed to determine the exact relationship between DPP-4 inhibitors, BP, and psoriasis. Four months after the start of treatment with linagliptin, the epithelial layer is seen detaching from the dermis, and an inflammatory infiltrate is present (hematoxylin-eosin, original magnification ×10).
Primary Melanoma of the Penis in 3 Patients With Lichen Sclerosus
Genital lichen sclerosus (GLSc) is associated with squamous cell carcinoma (SCC), although the precise cause is not known. We describe 3 male patients with GLSc and primary penile melanoma. To our knowledge, a possible association between lichen sclerosus and primary penile melanoma has not previously been discussed.
Report of Cases | Case 1. A man in his 50s presented with a firm nodule growing in the left coronal sulcus over 4 months ( Figure) . Three years earlier, he had been diagnosed with GLSc and unsuccessfully treated with topical steroid preparations of various potencies. Ultimately, he underwent a curative circumcision that same year with histological confirmation of GLSc. Clinically, SCC was suspected, and an excisional biopsy was performed that showed a primary nodular melanoma with a Breslow thickness of 1.2 mm and Clark level 5. Ulceration was seen. Perineural, vascular, and lymphatic invasion were absent. Excision was incomplete, but the patient declined further surgery.
There was some clinical and histologic uncertainty whether the penile lesion was a secondary deposit rather than a primary melanoma. Meticulous clinical examination and extensive initial staging revealed no alternative primary nor metastatic disease. Two months later he developed subcutaneous melanoma deposits on his chest as well as pulmonary and liver metastases. He declined chemotherapy and was treated palliatively until he died.
Case 2. A man in his 30s presented with a 1-year history of a slowly growing pigmented lesion on the glans of the penis. Clinically, melanoma was suspected, but he also had signs of active GLSc (a tight, scarred frenulum and a constrictive posthitis). An excisional biopsy showed a narrowly excised early radial growth phase mucosal lentiginous melanoma, Breslow thickness of 0.1 mm. He underwent wider excisional surgery and was also circumcised. The foreskin histologic analysis demonstrated GLSc. At last follow-up, he remained alive and well.
Case 3. A man in his 40s presented with a pigmented macule of the glans penis of uncertain provenance. He had white sclerotic lesions of the glans and foreskin, biopsy of which confirmed GLSc. Histologic analysis of specimens from the pigmented lesion showed early radial growth phase melanoma with a Breslow thickness of 0.44 mm. The melanoma was completely excised, and a circumcision was performed. At last follow-up, the patient remained alive and well.
Discussion | Male GLSc is a lymphocyte-mediated dermatosis of controversial pathogenesis, but the weight of evidence points to chronic occluded exposure of a susceptible epithelium to urine.
1 It is thought that chronic inflammation and scarring due to GLSc are the drivers to SCC. 2 The published rates of this complication range from 0% to 12.5%.
2
Squamous cell carcinomas constitute 95% of penile cancers. Penile melanoma is responsible for less than 1% 3 and typically occurs in the sixth and seventh decades of life; 50% occurs on the glans. 4 It has an extremely poor prognosis (5-year survival, 31%). 5 Although UV radiation is important in the pathogenesis of cutaneous melanoma, the cause of genital mucosal disease is obscure. Primary vulval melanoma has been reported in women with coexisting GLSc. A possible causal relationship has been discussed, 6 involving a pro-oxidative environment that increases the risk of mutations and disruptions of local mechanisms protecting against "melanocyte carcinogen." However, the investigators note that the finding may be coincidental rather than causal.
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To our knowledge, no cases of concomitant penile melanoma and GLSc have previously been reported. The occurrence of melanoma and GLSc observed in the 3 patients we describe herein may be a coincidence, but in 22 years of providing a dedicated genital dermatology service, these are the only penile melanomas that we have seen. In other words, no penile melanomas have been seen in the absence of GLSc. This clinical image shows a firm nodule growing in the left coronal sulcus of the penis that was later confirmed to be melanoma.
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